Paracetamol in pregnancy may lower testosterone in unborn boys

May 20, 2015, University of Edinburgh
Tylenol 500 mg capsules. Credit: Wikipedia

Prolonged paracetamol use by pregnant women may reduce testosterone production in unborn baby boys, research has found.

Researchers say their findings could help to explain reported links between paracetamol use in pregnancy and reproductive health problems in young boys.

Paracetamol is the primary medicine used for managing pain and fever during pregnancy.

The authors recommend that expectant mothers should follow existing guidelines that the painkiller be taken at the lowest effective dose for the shortest possible time.

Testosterone, produced in the testicles, is crucial for life-long male health. Reduced exposure to the hormone in the womb has been linked to an increased risk of infertility, testicular cancer and undescended testicles.

The University of Edinburgh study tested the effect of paracetamol on testosterone production in mice that carried grafts of human testicular tissue. These grafts have been shown to mimic how the developing testes grow and function during pregnancy.

Scientists gave the mice a typical daily dose of paracetamol - over a period of either 24 hours or seven days. They measured the amount of testosterone produced by the human tissue an hour after the final dose of paracetamol.

They found there was no effect on testosterone production following 24 hours of paracetamol treatment. After seven days of exposure, however, the amount of was reduced by 45 per cent.

The team - from the University's MRC Centre for Reproductive Health - say further research is required to establish the mechanism by which paracetamol might have this effect.

The study is published in the journal Science Translational Medicine. It is funded by the Wellcome Trust, the British Society of Paediatric Endocrinology and Diabetes and the Medical Research Council.

Dr Rod Mitchell, a Wellcome Trust Intermediate Clinical Research Fellow at the University of Edinburgh, said: "This study adds to existing evidence that prolonged use of in may increase the risk of reproductive disorders in male babies.

"We would advise that should follow current guidance that the painkiller be taken at the lowest effective dose for the shortest possible time."

Explore further: Reported link between early life exposure to paracetamol and asthma 'overstated'

More information: S. van den Driesche et al. Prolonged exposure to acetaminophen reduces testosterone production by the human fetal testis in a xenograft model. Science Translational Medicine, 20 May 2015. stm.sciencemag.org/lookup/doi/ … scitranslmed.aaa4097

Related Stories

Reported link between early life exposure to paracetamol and asthma 'overstated'

November 25, 2014
Respiratory infections are likely to have an influential role, the findings suggest. And the evidence is simply not strong enough to warrant changes to current guidance on the use of this medicine, say the researchers.

Paracetamol is ineffective for lower back pain

March 31, 2015
Paracetamol is not effective in the treatment of spinal pain and provides negligible benefits for osteoarthritis, according to a study published in The BMJ today.

Sweden bans supermarket paracetemol sales after overdose hike

April 29, 2015
Sweden said Wednesday that it will ban the sale of paracetamol tablets in supermarkets due to a sharp rise in overdoses in the six years since they became available outside of pharmacies.

Risks of taking paracetamol long-term may have been underestimated by clinicians

March 2, 2015
Doctors may have underestimated the risks for patients who take paracetamol long-term, suggests research published online in the Annals of the Rheumatic Diseases.

Male health linked to testosterone exposure in womb, study finds

April 22, 2014
Men's susceptibility to serious health conditions may be influenced by low exposure to testosterone in the womb, new research suggests.

Paracetamol poisoning treatment guidelines costing NHS millions

March 26, 2014
Strict guidelines for treating paracetamol overdoses – introduced 18 months ago – are costing the NHS millions of pounds a year, researchers claim.

Recommended for you

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

Study finds no strong evidence that cannabis reduces chronic pain

July 4, 2018
A four-year study suggests medicinal cannabis is not as effective at relieving chronic non-cancer pain as commonly assumed.

Expanding primary care buprenorphine treatment could curb opioid overdose crisis

July 4, 2018
Expanding the availability of medication treatment for opioid use disorder in primary care settings would be a major step toward reducing overdose deaths, write two physicians specializing in addiction medicine and health ...

Chronic pain remains the same or gets better after stopping opioid treatment: study

July 2, 2018
Stopping long-term opioid treatment does not make chronic, non-cancer-related pain worse and, in some cases, makes it better, Washington State University researchers have found.

Pain relief at a lower opioid dose

June 25, 2018
A team of researchers at Johns Hopkins have found that activating nerve cell receptors along two chemical pathways—one that has previously been linked to how the brain senses "itch"—may improve pain relief when combined ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.